** Shares of digital healthcare services platform Phreesia PHR.N rise as much as 4.2% to $28.10, the highest since February 2024
** Brokerage RBC Capital Markets upgrades the stock to "outperform" from "sector perform", raises PT by $8 to $32
** Sees company's average revenue per client growth accelerating, on increasing Network Solutions segment momentum, cross-selling of several newer provider add-ons and signing of new clients with bigger initial solution bundles
** Also sees company's operating cost base remaining stable, and helping to generate significant operating leverage
** Fifteen brokerages rate the stock "buy" or higher; with a median PT of $30, according to data compiled by LSEG
** PHR sales rose 8.7% last year
(Reporting by Neil J Kanatt in Bengaluru)
((Neil.JKanatt@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.